These may include nausea, vomiting, diarrhea, and mild gastrointestinal discomfort
However, their effect on gastric emptying can alter the absorption of oral medications administered concurrently
7 Exenatide (Byetta, Bydureon): Primarily used to manage type 2 diabetes, exenatide is available under two brand names in the US
Triple Agonist vs Dual Agonist Comparison Contents Key Takeaways Two Compounds, One Manufacturer, Different Receptor Counts Weight Loss: The Numbers Side by Side Mechanism Breakdown: What the Third Receptor Adds Safety: Where the Tradeoffs Appear Evidence Quality: Phase 2 vs Phase 3 Where Each Compound Might Win The Bottom Line Explore Research Peptides Retatrutide 12mg 24.2% body weight lost (Phase 2, 48 wk) vs Tirzepatide 15mg 22.5% body weight lost (Phase 3, 72 wk) 3 vs 2 receptor targets (retatrutide vs tirzepatide) 63% vs 57% reached 20%+ weight loss (highest dose arms) Eli Lilly same manufacturer for both compounds Sources: Retatrutide Phase 2 (NEJM, 2023), SURMOUNT-1 (NEJM, 2022)
Serving size is 2 Capsule(s), with 60 servings per container and $0.53 per serving
KnerrPJMowerySADourosJDPremdjeeBHjllundKRHeYet al